Two-year study of etanercept in pediatric patients with JIA, PsA shows …

Two-year study of etanercept in pediatric patients with JIA, PsA shows …

A sustained response was observed in pediatric patients with juvenile idiopathic arthritis, enthesitis-related arthritis, psoriatic arthritis or extended oligoarthritis treated with etanercept over 96 weeks with no serious adverse events, according to

(Visited 2 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.